Picture of ExpreS2ion Biotech Holding AB logo

EXPRS2 — ExpreS2ion Biotech Holding AB News Story

0.000.00%
se flag iconLast trade - 00:00
HealthcareHighly SpeculativeMicro CapSucker Stock

Brief: Expres2ion Q4 Loss After Financial Items Widens To SEK 53.3 Mln

Feb 9 (Reuters) - ExpreS2ion Biotech Holding AB
 EXPRS2.ST :
    * EXPRES2ION ANNOUNCES FINANCIAL RESULTS FOR THE FOURTH
QUARTER
AND FULL-YEAR 2022
    * Q4 OPERATING INCOME AMOUNTED TO 1,583 (4,430) KSEK
    * Q4 LOSS AFTER FINANCIAL ITEMS AMOUNTED TO -53,287
(-14,944) KSEK

Source text for Eikon:  ID:nWkr7LgQxM 
Further company coverage:  EXPRS2.ST 
 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))

Recent news on ExpreS2ion Biotech Holding AB

See all news